Augmentation therapy with alpha1-antitrypsin: Novel perspectives

Cardiovascular and Hematological Disorders - Drug Targets

Volumn 13, Issue 2, 2013, Pages 90-98

  Sabina, Janciauskiene ^a   Tobias, Welte ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Alpha1 antitrypsin deficiency; Augmentation therapy; Diseases; Inflammation; Peptides; Therapy

Indexed keywords

ALPHA 1 ANTITRYPSIN; ANTIBIOTIC AGENT; CORTICOSTEROID; DOXYCYCLINE; GELATINASE B; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 8;

ACUTE HEART INFARCTION; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; ASTHMA; CYSTIC FIBROSIS; DENSITOMETRY; DIABETES MELLITUS; ENTERITIS; ENZYME REPLACEMENT; FIBROMYALGIA; FORCED EXPIRATORY VOLUME; GENE MUTATION; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LIVER INJURY; LUNG EMPHYSEMA; LUNG INFECTION; MULTIPLE SCLEROSIS; NONHUMAN; PANNICULITIS; PLASMAPHERESIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPERFUSION INJURY; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT INDICATION; VASCULITIS;

ALPHA 1-ANTITRYPSIN; ALPHA 1-ANTITRYPSIN DEFICIENCY; ANIMALS; HUMANS; INFLAMMATION; PULMONARY EMPHYSEMA;

EID: 84888111448     PISSN: 1871529X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1871529X11313020002     Document Type: Article

References (110)

1. Carrell, R.W.; Owen, M.C. Plakalbumin, alpha 1-antitrypsin, antithrombin and the mechanism of inflammatory thrombosis. Nature, 1985, 317(6039), 730-732.
2. Janciauskiene, S. Conformational properties of serine proteinase inhibitors (serpins) confer multiple pathophysiological roles. Biochim. Biophys. Acta, 2001, 1535(3), 221-235.
3. Carrell, R.W.; Lomas, D.A. Conformational disease. Lancet, 1997, 350(9071), 134-138.
4. Ekeowa, U.I.; Marciniak, S.J.; Lomas, D.A. alpha(1)-antitrypsin deficiency and inflammation. Expert Rev. Clin. Immunol., 2011, 7(2), 243-252.
5. Mohanka, M.; Khemasuwan, D.; Stoller, J.K. A review of augmentation therapy for alpha-1 antitrypsin deficiency. Expert. Opin. Biol. Ther., 2012, 12(6), 685-700.
6. Stoller, J.K.; Snider, G.L.; Brantly, M.L.; Fallat, R.J.; Stockley, R.A.; Turino, G.M.; Konietzko, N.; Dirksen, A.; Eden, E.; Luisetti, M.; Stolk, J.; Strange, C.; American Thoracic, S.; European Respiratory, S, [American Thoracic Society/European Respiratory Society Statement: Standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency]. Pneumologie, 2005, 59(1), 36-68.
7. Wencker, M.; Fuhrmann, B.; Banik, N.; Konietzko, N.; Wissenschaftliche Arbeitsgemeinschaft zur Therapie von, L. Longitudinal follow-up of patients with alpha(1)-protease inhibitor deficiency before and during therapy with IV alpha(1)-protease inhibitor. Chest, 2001, 119 (3), 737-744.
8. [] Dirksen, A.; Piitulainen, E.; Parr, D.G.; Deng, C.; Wencker, M.; Shaker, S.B.; Stockley, R.A. Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha1-antitrypsin deficiency. Eur. Respir. J., 2009, 33(6), 1345-1353.
9. Parr, D.G.; Dirksen, A.; Piitulainen, E.; Deng, C.; Wencker, M.; Stockley, R.A. Exploring the optimum approach to the use of CT densitometry in a randomised placebo-controlled study of augmentation therapy in alpha 1-antitrypsin deficiency. Respir. Res., 2009, 10, 75.
10. Stockley, R.A.; Parr, D.G.; Piitulainen, E.; Stolk, J.; Stoel, B.C. Dirksen, A. Therapeutic efficacy of alpha-1 antitrypsin augmentation therapy on the loss of lung tissue: an integrated analysis of 2 randomised clinical trials using computed tomography densitometry. Respir. Res., 2010, 11, 136.
11. Janciauskiene, S.M.; Bals, R.; Koczulla, R.; Vogelmeier, C.; Kohnlein, T.; Welte, T. The discovery of alpha1-antitrypsin and its role in health and disease. Respir. Med., 2011, 105(8), 1129-1139.
12. Lyon, M.J. Metabolic panniculitis: alpha-1 antitrypsin deficiency panniculitis and pancreatic panniculitis. Dermatol. Ther., 2010, 23(4), 368-374.
13. [] Valverde, R.; Rosales, B.; Ortiz-de Frutos, F.J.; Rodriguez-Peralto, J.L.; Ortiz-Romero, P.L. Alpha-1-antitrypsin deficiency panniculitis. Dermatol. Clin., 2008, 26(4), 447-451, vi.
14. Esnault, V.L.; Audrain, M.A.; Sesboue, R. Alpha-1-antitrypsin phenotyping in ANCA-associated diseases: one of several arguments for protease/antiprotease imbalance in systemic vasculitis. Exp. Clin. Immunogenet., 1997, 14(3), 206-213.
15. Ranes, J.; Stoller, J.K. A review of alpha-1 antitrypsin deficiency. Semin. Respir. Crit. Care Med., 2005, 26(2), 154-166.
16. Breit, S.N.; Wakefield, D.; Robinson, J.P.; Luckhurst, E.; Clark, P.; Penny, R. The role of alpha 1-antitrypsin deficiency in the pathogenesis of immune disorders. Clin. Immunol. Immunopathol., 1985, 35(3), 363-380.
17. Teh, L.G.; Steven, M.M.; Capell, H.A. Alpha-1-antitrypsin associated liver disease in rheumatoid arthritis. Postgrad. Med. J., 1985, 61(712), 171-172.
18. Kilty, S.J.; Desrosiers, M.Y. Chronic sinusitis and alpha1-antitrypsin deficiency: potential role for protease in rhinosinusitis? J. Otolaryngol. Head Neck. Surg., 2008, 37(6), E179-E182.
19. Maune, S.; Rath, N.F.; Gorogh, T.; Steinert, R. [Genetic disposition to chronic polypoid sinusitis and alpha 1-proteinase inhibitor deficiency types]. HNO, 1995, 43(9), 537-539.
20. Fearnley, I.R.; Spalton, D.J.; Ward, A.M.; Slavin, B.; Muncey, F Alpha 1-antitrypsin phenotypes in acute anterior uveitis. Br J. Ophthalmol., 1988, 72(8), 636-639.
21. Needham, M.; Stockley, R.A. Alpha 1-antitrypsin deficiency. 3: Clinical manifestations and natural history. Thorax, 2004, 59(5), 441-445.
22. Rabassa, A.A.; Schwartz, M.R.; Ertan, A. Alpha 1-antitrypsin deficiency and chronic pancreatitis. Dig. Dis. Sci., 1995, 40(9), 1997-2001.
23. Witt, H.; Kage, A.; Luck, W.; Becker, M. Alpha1-antitrypsin genotypes in patients with chronic pancreatitis. Scand. J. Gastroenterol., 2002, 37(3), 356-359.
24. Folwaczny, C.; Urban, S.; Schroder, M.; Hofmann, B.; Noehl, N. Konig, A.; Loeschke, K.; Fricke, H. Alpha1-antitrypsin alleles and phenotypes in patients with inflammatory bowel disease. Scand. J. Gastroenterol., 1998, 33(1), 78-81.
25. Gambichler, T.; Reich, S.; Banasch, M.; Altmeyer, P. Complex extra-intestinal complications of ulcerative colitis in a patient with alpha1-antitrypsin deficiency. Eur. J. Med. Res., 2006, 11(3), 135-138.
26. Klasen, E.C.; Polanco, I.; Biemond, I.; Vazquez, C.; Pena, A.S. alpha 1-Antitrypsin and coeliac disease in spain. Gut, 1980, 21(11), 948-950.
27. Pons Romero, F.; Casafont, F.; Rodriguez de Lope, C.; San Miguel, G.; Artinano, E.; Cagigas, J. Could alpha 1 antitrypsin deficiency have any role in the development of celiac sprue after gastric operations? J. Clin. Gastroenterol., 1986, 8(5), 559-561.
28. Andre, F.; Andre, C.; Lambert, R.; Descos, F. Prevalence of alpha1-antitrypsin deficiency in patients with gastric or duodenal ulcer. Biomedicine, 1974, 21(5), 222-224.
29. Elzouki, A.N.; Toth, E.; Floren, C.H.; Lindgren, S.; Fork, F.T. Sjolund, K.; Walder, M.; Eriksson, S. Alpha1-antitrypsin deficiency may be a risk factor for duodenal ulcer in patients with Helicobacter pylori infection. Scand J. Gastroenterol., 2000, 35(1), 32-35.
30. Shapiro, L.; Pott, G.B.; Ralston, A.H. Alpha-1-antitrypsin inhibits human immunodeficiency virus type 1. FASEB J., 2001, 15(1), 115-122.
31. Lisowska-Myjak, B.; Pachecka, J.; Kaczynska, B.; Miszkurka, G.; Kadziela, K. Serum protease inhibitor concentrations and total antitrypsin activity in diabetic and non-diabetic children during adolescence. Acta Diabetol., 2006, 43(4), 88-92.
32. Sandstrom, C.S.; Ohlsson, B.; Melander, O.; Westin, U. Mahadeva, R.; Janciauskiene, S. An association between Type 2 diabetes and alpha-antitrypsin deficiency. Diabet. Med., 2008, 25(11), 1370-1373.
33. Callea, F.; Fevery, J.; Desmet, V.J. Simultaneous alpha-1-antitrypsin accumulation in liver and pancreas. Hum. Pathol., 1984, 15(3), 293-295.
34. Dieriks, B.; Hoorens, A.; Vanden Houte, K.; Verbeelen, D. Alpha-1-antitrypsin deficiency and mesangio-capillary glomerulonephritis in an elderly patient. Nephrol. Dial. Transplant., 2006, 21(7), 2027.
35. Szonyi, L.; Dobos, M.; Vasarhelyi, B.; Heninger, E.; Vas, T.; Nagy, J.; Kovacs, T. Prevalence of alpha1-antitrypsin phenotypes in patients with IgA nephropathy. Clin. Nephrol., 2004, 62(6), 418- 422.
36. Ting, S.M.; Toth, T.; Caskey, F. alpha1-antitrypsin (A1AT) deficiency presenting with IgA nephropathy and nephrotic syndrome: is renal involvement caused by A1AT deposition? Clin. Nephrol., 2008, 70(2), 159-162.
37. Ablin, J.N.; Bar-Shira, A.; Yaron, M.; Orr-Urtreger, A. Candidate-gene approach in fibromyalgia syndrome: association analysis of the genes encoding substance P receptor, dopamine transporter and alpha1-antitrypsin. Clin. Exp. Rheumatol., 2009, 27(5 Suppl 56), S33-38.
38. Blanco, I.; Janciauskiene, S.; Nita, I.; Fernandez-Bustillo, E. Carcaba, V.; Gallo, C.; Alvarez-Rico, M.; de Serres, F.; Beridze, N. Low plasma levels of monocyte chemoattractant protein-1 (MCP-1), tumor necrosis factor-alpha (TNFalpha), and vascular endothelial growth factor (VEGF) in patients with alpha1-antitrypsin deficiency-related fibromyalgia. Clin. Rheumatol., 2010, 29(2), 189-197.
39. Schelfout, K.; Tjalma, W.A.; Cooremans, I.D.; Coeman, D.C.; Colpaert, C.G.; Buytaert, P.M. Observations of an idiopathic granulomatous mastitis. Eur. J. Obstet. Gynecol. Reprod. Biol., 2001, 97 (2), 260-262.
40. Frederick, W.G.; Enriquez, R.; Bookbinder, M.J. Peripheral neuropathy associated with alpha 1-antitrypsin deficiency. Arch. Neurol., 1990, 47(2), 233-235.
41. Elzouki, A.N.; Eriksson, S. Severe alpha 1-antitrypsin deficiency and intracranial aneurysms. Lancet, 1994, 343(8904), 1037.
42. Elzouki, A.N.; Ryden Ahlgren, A.; Lanne, T.; Sonesson, B.; Eriksson, S. Is there a relationship between abdominal aortic aneurysms and alpha1-antitrypsin deficiency (PiZ)? Eur. J. Vasc. Endovasc. Surg., 1999, 17(2), 149-154.
43. Gaglio, P.J.; Regenstein, F.; Slakey, D.; Cheng, S.; Takiff, H.; Rinker, R.; Dick, D.; Thung, S.N. Alpha-1 antitrypsin deficiency and splenic artery aneurysm rupture: an association? Am. J. Gastroenterol., 2000, 95(6), 1531-1534.
44. Pezzini, A.; Magoni, M.; Corda, L.; Pini, L.; Medicina, D.; Crispino, M.; Pavia, M.; Padovani, A.; Grassi, V. Alpha-1- antitrypsin deficiency-associated cervical artery dissection: report of three cases. Eur. Neurol., 2002, 47(4), 201-204.
45. Schardey, H.M.; Hernandez-Richter, T.; Klueppelberg, U.; Tutsch- Bauer, E.; Lauterjung, L. Alleles of the alpha-1-antitrypsin phenotype in patients with aortic aneurysms. J. Cardiovasc. Surg. (Torino), 1998, 39(5), 535-539.
46. Talmud, P.J.; Martin, S.; Steiner, G.; Flavell, D.M.; Whitehouse, D.B.; Nagl, S.; Jackson, R.; Taskinen, M.R.; Frick, M.H.; Nieminen, M.S.; Kesaniemi, Y.A.; Pasternack, A.; Humphries, S.E.; Syvanne, M.; Diabetes Atherosclerosis Intervention Study, I. Progression of atherosclerosis is associated with variation in the alpha1-antitrypsin gene. Arterioscler. Thromb. Vasc. Biol., 2003, 23 (4), 644-649.
47. Francalanci, P.; Santorelli, F.M.; Saccani, S.; Bonetti, M.F.; Medicina, D.; Coni, P.; Faa, G.; Callea, F. Z and Mmalton-1- antitrypsin deficiency-associated hepatocellular carcinoma: a genetic study. Liver Int., 2009, 29(10), 1593-1596.
48. Li, Y.; Krowka, M.J.; Qi, Y.; Katzmann, J.A.; Song, Y.; Mandrekar, S.J.; Yang, P. Alpha1-antitrypsin deficiency carriers, serum alpha 1-antitrypsin concentration, and non-small cell lung cancer survival. J Thorac Oncol, 2011, 6(2), 291-295.
49. Lindor, N.M.; Yang, P.; Evans, I.; Schowalter, K.; De Andrade, M.; Li, J.; Jeavons, E.; Peterson, G.; Gallinger, S.; Bapat, B.; Hopper, J.; Jass, J.; Jenkins, M.; Templeton, A.; Potter, J.; Newcomb, P.A.; Lemarchand, L.; Grove, J.; Haile, R.; Baron, J.; Seminara, D.; Limburg, P.; Thibodeau, S.N. Alpha-1-antitrypsin deficiency and smoking as risk factors for mismatch repair deficient colorectal cancer: a study from the colon cancer family registry. Mol. Genet. Metab., 2010, 99(2), 157-159.
50. Topic, A.; Ljujic, M.; Nikolic, A.; Petrovic-Stanojevic, N.; Dopudja-Pantic, V.; Mitic-Milikic, M.; Radojkovic, D. Alpha-1- antitrypsin phenotypes and neutrophil elastase gene promoter polymorphisms in lung cancer. Pathol. Oncol. Res., 2011, 17(1), 75-80.
51. Yang, P.; Sun, Z.; Krowka, M.J.; Aubry, M.C.; Bamlet, W.R.; Wampfler, J.A.; Thibodeau, S.N.; Katzmann, J.A.; Allen, M.S.; Midthun, D.E.; Marks, R.S.; de Andrade, M. Alpha1-antitrypsin deficiency carriers, tobacco smoke, chronic obstructive pulmonary disease, and lung cancer risk. Arch. Intern. Med., 2008, 168(10), 1097-1103.
52. McElvaney, N.G.; Stoller, J.K.; Buist, A.S.; Prakash, U.B.; Brantly, M.L.; Schluchter, M.D.; Crystal, R.D. Baseline characteristics of enrollees in the National Heart, Lung and Blood Institute Registry of alpha 1-antitrypsin deficiency. Alpha 1-Antitrypsin Deficiency Registry Study Group. Chest, 1997, 111 (2), 394-403.
53. Piliang, M.P.; Stoller, J.K. Women with ulcerating, painful skin lesions. Cleve. Clin. J. Med., 2008, 75(6), 414, 418-422.
54. Gaillard, M.C.; Bothwell, J.; Dreyer, L. A case of systemic nodular panniculitis associated with M1 (Val213) Z phenotype of alpha 1- protease inhibitor. Int. J. Dermatol., 1997, 36(4), 278-280.
55. Pinto, A.R.; Maciel, L.S.; Carneiro, F.; Resende, C.; Chaves, F.C.; Freitas, A.F. Systemic nodular panniculitis in a patient with alpha-1 antitrypsin deficiency (PiSS phenotype). Clin. Exp. Dermatol., 1993, 18(2), 154-155.
56. Elzouki, A.N.; Segelmark, M.; Wieslander, J.; Eriksson, S. Strong link between the alpha 1-antitrypsin PiZ allele and Wegener's granulomatosis. J. Intern. Med., 1994, 236(5), 543-548.
57. Griffith, M.E.; Lovegrove, J.U.; Gaskin, G.; Whitehouse, D.B.; Pusey, C.D. C-antineutrophil cytoplasmic antibody positivity in vasculitis patients is associated with the Z allele of alpha-1- antitrypsin, and P-antineutrophil cytoplasmic antibody positivity with the S allele. Nephrol. Dial. Transplant., 1996, 11(3), 438-443.
58. Segelmark, M.; Elzouki, A.N.; Wieslander, J.; Eriksson, S. The PiZ gene of alpha 1-antitrypsin as a determinant of outcome in PR3- ANCA-positive vasculitis. Kidney Int., 1995, 48(3), 844-850.
59. Mahr, A.D.; Edberg, J.C.; Stone, J.H.; Hoffman, G.S.; St Clair, E.W.; Specks, U.; Dellaripa, P.F.; Seo, P.; Spiera, R.F.; Rouhani, F.N.; Brantly, M.L.; Merkel, P.A. Alpha(1)-antitrypsin deficiencyrelated alleles Z and S and the risk of Wegener's granulomatosis. Arthritis. Rheum., 2010, 62(12), 3760-3767.
60. Furey, N.L.; Golden, R.S.; Potts, S.R. Treatment of alpha-1- antitrypsin deficiency, massive edema, and panniculitis with alpha- 1 protease inhibitor. Ann. Intern. Med., 1996, 125(8), 699.
61. Gross, B.; Grebe, M.; Wencker, M.; Stoller, J.K.; Bjursten, L.M.; Janciauskiene, S. New Findings in PiZZ alpha1-antitrypsin deficiency-related panniculitis. Demonstration of skin polymers and high dosing requirements of intravenous augmentation therapy. Dermatology, 2009, 218(4), 370-375.
62. O'Riordan, K.; Blei, A.; Rao, M.S.; Abecassis, M. alpha 1- antitrypsin deficiency-associated panniculitis: resolution with intravenous alpha 1-antitrypsin administration and liver transplantation. Transplantation, 1997, 63(3), 480-482.
63. Irvine, C.; Neild, V.; Stephens, C.; Black, M. Alpha-1-antitrypsin deficiency panniculitis. JR. Soc. Med., 1990, 83(11), 743-744.
64. Ortiz, P.G.; Skov, B.G.; Benfeldt, E. Alpha1-antitrypsin deficiency-associated panniculitis: case report and review of treatment options. J. Eur. Acad. Dermatol. Venereol., 2005, 19(4), 487-490.
65. Chowdhury, M.M.; Williams, E.J.; Morris, J.S.; Ferguson, B.J.; McGregor, A.D.; Hedges, A.R.; Stamatakis, J.D.; Pope, F.M. Severe panniculitis caused by homozygous ZZ alpha1-antitrypsin deficiency treated successfully with human purified enzyme (Prolastin). Br. J. Dermatol., 2002, 147 (6), 1258-1261.
66. Olson, J.M.; Moore, E.C.; Valasek, M.A.; Williams, L.H.; Vary, J.C. Panniculitis in alpha-1 antitrypsin deficiency treated with enzyme replacement. J. Am. Acad. Dermatol., 2012, 66(4), e139-141.
67. Dowd, S.K.; Rodgers, G.C.; Callen, J.P. Effective treatment with alpha 1-protease inhibitor of chronic cutaneous vasculitis associated with alpha 1-antitrypsin deficiency. J. Am. Acad. Dermatol., 1995, 33(5 Pt 2), 913-916.
68. Blanco, I.; Canto, H.; de Serres, F.J.; Fernandez-Bustillo, E.; Rodriguez, M.C. Alpha1-antitrypsin replacement therapy controls fibromyalgia symptoms in 2 patients with PI ZZ alpha1-antitrypsin deficiency. J. Rheumatol., 2004, 31(10), 2082-2085.
69. Blanco, I.B.; Astudillo, A.; D., I.F.; Janciauskiene, S.; Fernandez, V.C.; Alvaro, C.G.; Argiz, H.C.; de Serres, F.J.; Bustillo, E.F. Intravenous infusions of purified alpha-1 antitripsyn effectively controls symptoms and reverts muscle biopsy changes in an MZ alpha-1 antitripsyn deficiency and fibromyalgia syndrome patient. J. Musculoskel. Pain, 2010, 18(2), 167-172.
70. Blanco, I.; Canto, H.; Flores, J.; Camblor, C.; Carcaba, V.; de Serres, F.J.; Janciauskiene, S.; Bustillo, E.F. Long-term augmentation therapy with alpha-1 antitrypsin in an MZ-AAT severe persistent asthma. Monaldi. Arch Chest Dis., 2008, 69(4), 178-182.
71. Griese, M.; Latzin, P.; Kappler, M.; Weckerle, K.; Heinzlmaier, T.; Bernhardt, T.; Hartl, D. alpha1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients. Eur. Respir. J., 2007, 29(2), 240-250.
72. Siekmeier, R. Lung deposition of inhaled alpha-1-proteinase inhibitor (alpha 1-PI) - problems and experience of alpha1-PI inhalation therapy in patients with hereditary alpha1-PI deficiency and cystic fibrosis. Eur. J. Med. Res., 2010, 15(2), 164-174.
73. Gettins, P.G. Serpin structure, mechanism, and function. Chem. Rev., 2002, 102, 4751-4804.
74. Luo, L.Y.; Jiang, W. Inhibition profiles of human tissue kallikreins by serine protease inhibitors. Biol. Chem., 2006, 387(6), 813-816.
75. Schapira, M.; Scott, C.F.; Colman, R.W. Contribution of plasma protease inhibitors to the inactivation of kallikrein in plasma. J. Clin. Invest., 1982, 69(2), 462-468.
76. Janciauskiene, S.; Nita, I.; Subramaniyam, D.; Li, Q.; Lancaster, J.R., Jr.; Matalon, S. Alpha1-antitrypsin inhibits the activity of the matriptase catalytic domain in vitro. Am. J. Respir. Cell Mol. Biol., 2008, 39(6), 631-637.
77. Tseng, I.C.; Chou, F.P.; Su, S.F.; Oberst, M.; Madayiputhiya, N.; Lee, M.S.; Wang, J.K.; Sloane, D.E.; Johnson, M.; Lin, C.Y. Purification from human milk of matriptase complexes with secreted serpins: mechanism for inhibition of matriptase other than HAI-1. Am. J. Physiol. Cell Physiol., 2008, 295(2), C423-431.
78. Petrache, I.; Fijalkowska, I.; Medler, T.R.; Skirball, J.; Cruz, P.; Zhen, L.; Petrache, H.I.; Flotte, T.R.; Tuder, R.M. alpha-1 antitrypsin inhibits caspase-3 activity, preventing lung endothelial cell apoptosis. Am. J. Pathol., 2006, 169(4), 1155-1166.
79. Bergin, D.A.; Reeves, E.P.; Meleady, P.; Henry, M.; McElvaney, O.J.; Carroll, T.P.; Condron, C.; Chotirmall, S.H.; Clynes, M.; O'Neill, S.J.; McElvaney, N.G. alpha-1 Antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8. J. Clin. Invest., 2010, 120 (12), 4236-4250.
80. Al-Omari, M.; Korenbaum, E.; Ballmaier, M.; Lehmann, U.; Jonigk, D.; Manstein, D.J.; Welte, T.; Mahadeva, R.; Janciauskiene, S. Acute-phase protein alpha1-antitrypsin inhibits neutrophil calpain I and induces random migration. Mol. Med., 2011, 17(9-10), 865-874.
81. Janciauskiene, S.; Larsson, S.; Larsson, P.; Virtala, R.; Jansson, L.; Stevens, T. Inhibition of lipopolysaccharide-mediated human monocyte activation, in vitro, by alpha1-antitrypsin. Biochem. Biophys. Res. Commun., 2004, 321(3), 592-600.
82. Subramaniyam, D.; Virtala, R.; Pawlowski, K.; Clausen, I.G.; Warkentin, S.; Stevens, T.; Janciauskiene, S. TNF-alpha-induced self expression in human lung endothelial cells is inhibited by native and oxidized alpha1-antitrypsin. Int. J. Biochem. Cell Biol., 2008, 40(2), 258-271.
83. Hadzic, R.; Nita, I.; Tassidis, H.; Riesbeck, K.; Wingren, A.G.; Janciauskiene, S. Alpha1-antitrypsin inhibits Moraxella catarrhalis MID protein-induced tonsillar B cell proliferation and IL-6 release. Immunol. Lett., 2006, 102(2), 141-147.
84. Churg, A.; Dai, J.; Zay, K.; Karsan, A.; Hendricks, R.; Yee, C.; Martin, R.; MacKenzie, R.; Xie, C.; Zhang, L.; Shapiro, S.; Wright, J.L. Alpha-1-antitrypsin and a broad spectrum metalloprotease inhibitor, RS113456, have similar acute anti-inflammatory effects. Lab. Invest., 2001, 81(8), 1119-1131.
85. Bucurenci, N.; Blake, D.R.; Chidwick, K.; Winyard, P.G. Inhibition of neutrophil superoxide production by human plasma alpha 1-antitrypsin. FEBS Lett., 1992, 300(1), 21-24.
86. Chan, E.D.; Pott, G.B.; Silkoff, P.E.; Ralston, A.H.; Bryan, C.L.; Shapiro, L. Alpha-1-antitrypsin inhibits nitric oxide production. J. Leukoc. Biol., 2012, 92(6), 1251-1260.
87. Janciauskiene, S.M.; Nita, I.M.; Stevens, T. Alpha1-antitrypsin, old dog, new tricks. Alpha1-antitrypsin exerts in vitro antiinflammatory activity in human monocytes by elevating cAMP. J. Biol. Chem., 2007, 282(12), 8573-8582.
88. Tilg, H.; Vannier, E.; Vachino, G.; Dinarello, C.A.; Mier, J.W. Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells. J. Exp. Med., 1993, 178(5), 1629-1636.
89. Subramaniyam, D.; Steele, C.; Kohnlein, T.; Welte, T.; Grip, O.; Matalon, S.; Janciauskiene, S. Effects of alpha 1-antitrypsin on endotoxin-induced lung inflammation in vivo. Inflamm. Res., 2010, 59(7), 571-578.
90. Lockett, A.D.; Kimani, S.; Ddungu, G.; Wrenger, S.; Tuder, R.M.; Janciauskiene, S.M.; Petrache, I. Alpha-1 Antitrypsin Modulates Lung Endothelial Cell Inflammatory Responses to TNFalpha. Am. J. Respir. Cell Mol. Biol., 2013.
91. Liu, Z.; Zhou, X.; Shapiro, S.D.; Shipley, J.M.; Twining, S.S.; Diaz, L.A.; Senior, R.M.; Werb, Z. The serpin alpha1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo. Cell, 2000, 102(5), 647-655.
92. Jordon, R.E.; Kawana, S.; Fritz, K.A. Immunopathologic mechanisms in pemphigus and bullous pemphigoid. J. Invest. Dermatol., 1985, 85(1 Suppl), 72s-78s.
93. Zhou, J.; Trock, B.; Tsangaris, T.N.; Friedman, N.B.; Shapiro, D.; Brotzman, M.; Chan-Li, Y.; Chan, D.W.; Li, J. A unique proteolytic fragment of alpha1-antitrypsin is elevated in ductal fluid of breast cancer patient. Breast Cancer Res. Treat, 2010, 123(1), 73-86.
94. Münch, J.; Standker, L.; Adermann, K.; Schulz, A.; Schindler, M.; Chinnadurai, R.; Pohlmann, S.; Chaipan, C.; Biet, T.; Peters, T.; Meyer, B.; Wilhelm, D.; Lu, H.; Jing, W.; Jiang, S.; Forssmann, W.G.; Kirchhoff, F. Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide. Cell, 2007, 129(2), 263-275.
95. [] Forssmann, W.G.; The, Y.H.; Stoll, M.; Adermann, K.; Albrecht, U.; Barlos, K.; Busmann, A.; Canales-Mayordomo, A.; Gimenez- Gallego, G.; Hirsch, J.; Jimenez-Barbero, J.; Meyer-Olson, D.; Munch, J.; Perez-Castells, J.; Standker, L.; Kirchhoff, F.; Schmidt, R.E, Short-term monotherapy in HIV-infected patients with a virus entry inhibitor against the gp41 fusion peptide. Sci. Transl. Med., 2010, 2(63), 63re63.
96. Shapira, E.; Proscura, E.; Brodsky, B.; Wormser, U. Novel peptides as potential treatment of systemic lupus erythematosus. Lupus, 2011, 20(5), 463-472.
97. Gerbod-Giannone, M.C.; Del Castillo-Olivares, A.; Janciauskiene, S.; Gil, G.; Hylemon, P.B. Suppression of cholesterol 7alphahydroxylase transcription and bile acid synthesis by an alpha1- antitrypsin peptide via interaction with alpha1-fetoprotein transcription factor. J. Biol. Chem., 2002, 277(45), 42973-42980.
98. Bartz, R.; Fan, H.; Zhang, J.; Innocent, N.; Cherrin, C.; Beck, S.C.; Pei, Y.; Momose, A.; Jadhav, V.; Tellers, D.M.; Meng, F.; Crocker, L.S.; Sepp-Lorenzino, L.; Barnett, S.F. Effective siRNA delivery and target mRNA degradation using an amphipathic peptide to facilitate pH-dependent endosomal escape. Biochem. J., 2011, 435(2), 475-487.
99. Libert, C.; Van Molle, W.; Brouckaert, P.; Fiers, W. alpha1- Antitrypsin inhibits the lethal response to TNF in mice. J. Immunol., 1996, 157(11), 5126-5129.
100. Jie, Z.; Cai, Y.; Yang, W.; Jin, M.; Zhu, W.; Zhu, C. Protective effects of alpha 1-antitrypsin on acute lung injury in rabbits induced by endotoxin. Chin. Med. J. (Engl), 2003, 116(11), 1678-1682.
101. Cantin, A.M.; Woods, D.E. Aerosolized prolastin suppresses bacterial proliferation in a model of chronic Pseudomonas aeruginosa lung infection. Am. J. Respir. Crit. Care Med., 1999, 160(4), 1130-1135.
102. Lewis, E.C.; Mizrahi, M.; Toledano, M.; Defelice, N.; Wright, J.L.; Churg, A.; Shapiro, L.; Dinarello, C.A. alpha1-Antitrypsin monotherapy induces immune tolerance during islet allograft transplantation in mice. Proc. Natl. Acad. Sci. U S A, 2008, 105(42), 16236-16241.
103. Kalis, M.; Kumar, R.; Janciauskiene, S.; Salehi, A.; Cilio, C.M. alpha 1-antitrypsin enhances insulin secretion and prevents cytokine-mediated apoptosis in pancreatic beta-cells. Islets, 2010, 2 (3), 185-189.
104. Koulmanda, M.; Bhasin, M.; Hoffman, L.; Fan, Z.; Qipo, A.; Shi, H.; Bonner-Weir, S.; Putheti, P.; Degauque, N.; Libermann, T.A.; Auchincloss, H., Jr.; Flier, J.S.; Strom, T.B. Curative and beta cell regenerative effects of alpha1-antitrypsin treatment in autoimmune diabetic NOD mice. Proc. Natl. Acad. Sci. U S A, 2008, 105(42), 16242-16247.
105. Marcondes, A.M.; Li, X.; Tabellini, L.; Bartenstein, M.; Kabacka, J.; Sale, G.E.; Hansen, J.A.; Dinarello, C.A.; Deeg, H.J. Inhibition of IL-32 activation by alpha-1 antitrypsin suppresses alloreactivity and increases survival in an allogeneic murine marrow transplantation model. Blood, 2011, 118(18), 5031-5039.
106. Daemen, M.A.; Heemskerk, V.H.; van't Veer, C.; Denecker, G.; Wolfs, T.G.; Vandenabeele, P.; Buurman, W.A. Functional protection by acute phase proteins alpha(1)-acid glycoprotein and alpha(1)-antitrypsin against ischemia/reperfusion injury by preventing apoptosis and inflammation. Circulation, 2000, 102(12), 1420-1426.
107. Toldo, S.; Seropian, I.M.; Mezzaroma, E.; Van Tassell, B.W.; Salloum, F.N.; Lewis, E.C.; Voelkel, N.; Dinarello, C.A.; Abbate, A. Alpha-1 antitrypsin inhibits caspase-1 and protects from acute myocardial ischemia-reperfusion injury. J. Mol. Cell Cardiol., 2011, 51(2), 244-251.
108. Blanco, I.; Lara, B.; de Serres, F. Efficacy of alpha1-antitrypsin augmentation therapy in conditions other than pulmonary emphysema. Orphanet. J. Rare Dis., 2011, 6, 14.
109. Lewis, E.C. Expanding the clinical indications for alpha(1)- antitrypsin therapy. Mol. Med., 2012, 18, 957-970.
110. Grimstein, C.; Choi, Y.K.; Satoh, M.; Lu, Y.; Wang, X.; Campbell- Thompson, M.; Song, S. Combination of alpha-1 antitrypsin and doxycycline suppresses collagen-induced arthritis. J. Gene Med., 2010, 12(1), 35-44.